Program Overview
The program provides students with the knowledge and scientific background on the most recent pharmaceutical treatments available for different central nervous system pathologies. Clinical Neuropharmacology permits the students to investigate the structure and functions of the nervous system and the influence of the drugs on the nervous system. This will allow the students to apply the relevant knowledge to find novel targets and treatment for neurological and psychological disorders. The course is designed for students with a pharmacology background.
Vision Statement
To provide a high-quality program in teaching the concepts of neuropharmacology and to advance evidence-based treatment for neuropsychiatric and neurological disorders in Saudi Arabia.
Mission Statement
To equip the next generation of Saudi neuropharmacologists with the knowledge and expertise to deliver evidence-based treatments for neurological and psychiatric disorders while advancing drug development and research within Saudi Arabia.
Goals and Objectives
- Graduate highly competent neuropharmacologists capable of advancing knowledge through research and academia.
- Train specialists to apply neuropharmacology knowledge in treating neurological diseases.
- Support Saudi Arabia’s pharmaceutical industry with skilled scientists for drug discovery and development.
- Promote collaboration between Alfaisal University, King Fahad Medical City, and King Saud University.
Job Opportunities
Graduates of the program can pursue roles as clinical neuropharmacologists, clinical pharmacists specializing in neuropharmacology, research assistants, clinical research assistants, and healthcare advisors. They may also work in hospitals, pharmaceutical companies, research centres, and government authorities such as the Saudi FDA.
Admission Requirements
- A bachelor's degree accepted by The Ministry of Education (MOE) in a related field.
- A satisfactory scholastic average; a minimum grade average of "good" in the bachelor’s degree.
- Alfaisal Graduates or applicants who come from a country or political entity
where English is not the official language adequate proficiency in English to do
graduate work, as evidenced by
*English language tests are valid for three years.Clinical Neuropharmacology
IELTS (Academic)
5.5
TOEFL iBT
65
STEP
80
- Applicant should provide one recent letter of recommendation from professors who taught or from a manager at the workplace.
- The graduate study application must be accompanied by a non-refundable application fee payable to Alfaisal University, which is equal to SAR 600.
- An Interview with the applicant may be requested if necessary.
Duration
Clinical Neuropharmacology is a 2-year program
Tuition Fees
Students are allowed to repeat a maximum of 6 CH during their study without incurring extra fees. If students exceed the allowed CH, the normal CH rate will apply.
|
Description |
Amount (SAR) |
|
Application Fee (Non-Refundable) |
600 SAR |
|
Clinical Neuropharmacology Total Cost |
200,000 SAR |
|
Cost of credit hour |
4,762 SAR |
|
Seat Reservation and Tuition fee first instalment paid before the beginning of the Academic year/Registration (Non-Refundable) |
5000 SAR |